Moneycontrol PRO
HomeNewsBusinessCoronavirus Essential podcast | India's Biological E to produce 60 crore Johnson & Johnson vaccines this year; Delhi records zero deaths after nine months

Coronavirus Essential podcast | India's Biological E to produce 60 crore Johnson & Johnson vaccines this year; Delhi records zero deaths after nine months

Tune in to this podcast for all the top news on the pandemic.

February 10, 2021 / 17:35 IST

Hyderabad-based Biological E is planning to manufacture 60 crore doses of Johnson & Johnson COVID-19 vaccine a year, according to a  Reuters report. In August, Biological E had entered into an agreement with one of the Janssen Pharmaceutical companies of Johnson & Johnson for the manufacturing of the vaccine candidate.

No fresh coronavirus deaths were recorded in the national capital on the evening on Tuesday after a gap of about nine months while 100 fresh cases were registered with the Arvind Kejriwal government asserting that "Delhi's collective will is gradually winning over the infection".

Tune in to the Coronavirus Essential podcast for more.

Moneycontrol News
first published: Feb 10, 2021 05:35 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347